New Results
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Yandan Yang, Thomas Oellerich, Ping Chen, Arnold Bolomsky, Michele Ceribelli, Björn Häupl, George W. Wright, James D. Phelan, Da Wei Huang, James W. Lord, Callie K. Van Winkle, Xin Yu, Jan Wisnieski, James Q. Wang, Frances A. Tosto, Erin Beck, Kelli Wilson, Crystal McKnight, Jameson Travers, Carleen Klumpp-Thomas, Grace A. Smith, Stefania Pittaluga, Irina Maric, Dickran Kazandjian, Craig J. Thomas, Ryan M. Young
doi: https://doi.org/10.1101/2021.11.28.470260
Yandan Yang
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Thomas Oellerich
2Department of Medicine II, Heamatology/Oncology, Goethe University, Frankfurt, Germany
Ping Chen
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Arnold Bolomsky
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Michele Ceribelli
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Björn Häupl
2Department of Medicine II, Heamatology/Oncology, Goethe University, Frankfurt, Germany
George W. Wright
4Biometric Research Branch, DCTD, National Cancer Institute, National Institutes of Health, Bethesda MD
James D. Phelan
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Da Wei Huang
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
James W. Lord
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Callie K. Van Winkle
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Xin Yu
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Jan Wisnieski
5Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda MD
James Q. Wang
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Frances A. Tosto
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Erin Beck
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Kelli Wilson
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Crystal McKnight
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Jameson Travers
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Carleen Klumpp-Thomas
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Grace A. Smith
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Stefania Pittaluga
6Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Irina Maric
7Hematology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda MD
Dickran Kazandjian
8Department of Medicine, University of Miami Health System, Miami FL
Craig J. Thomas
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville MD
Ryan M. Young
1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda MD
Article usage
Posted November 28, 2021.
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Yandan Yang, Thomas Oellerich, Ping Chen, Arnold Bolomsky, Michele Ceribelli, Björn Häupl, George W. Wright, James D. Phelan, Da Wei Huang, James W. Lord, Callie K. Van Winkle, Xin Yu, Jan Wisnieski, James Q. Wang, Frances A. Tosto, Erin Beck, Kelli Wilson, Crystal McKnight, Jameson Travers, Carleen Klumpp-Thomas, Grace A. Smith, Stefania Pittaluga, Irina Maric, Dickran Kazandjian, Craig J. Thomas, Ryan M. Young
bioRxiv 2021.11.28.470260; doi: https://doi.org/10.1101/2021.11.28.470260
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Yandan Yang, Thomas Oellerich, Ping Chen, Arnold Bolomsky, Michele Ceribelli, Björn Häupl, George W. Wright, James D. Phelan, Da Wei Huang, James W. Lord, Callie K. Van Winkle, Xin Yu, Jan Wisnieski, James Q. Wang, Frances A. Tosto, Erin Beck, Kelli Wilson, Crystal McKnight, Jameson Travers, Carleen Klumpp-Thomas, Grace A. Smith, Stefania Pittaluga, Irina Maric, Dickran Kazandjian, Craig J. Thomas, Ryan M. Young
bioRxiv 2021.11.28.470260; doi: https://doi.org/10.1101/2021.11.28.470260
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)